{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:46:30Z","timestamp":1791405990439,"version":"4.3.3"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T00:00:00Z","timestamp":1096502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1038\/nm1113","type":"journal-article","created":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T18:11:13Z","timestamp":1096567873000},"page":"1055-1063","source":"Crossref","is-referenced-by-count":589,"title":["Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs"],"prefix":"10.1038","volume":"10","author":[{"given":"Mark S","family":"Forman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia M-Y","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,30]]},"reference":[{"key":"BFnm1113_CR1","first-page":"146","volume":"64","author":"A Alzheimer","year":"1907","unstructured":"Alzheimer, A. \u00dcber eine eigenartige Eskrankung der Nirnrinde. Allg. Z. Psychiatr. Psych.-Gerichtl. 64, 146\u2013148 (1907).","journal-title":"Allg. Z. Psychiatr. Psych.-Gerichtl."},{"key":"BFnm1113_CR2","first-page":"920","volume-title":"Handbuch der Neurologie","author":"F Lewy","year":"1912","unstructured":"Lewy, F. in Handbuch der Neurologie, 3, 920\u2013933. Springer Vertag, Berlin (1912)."},{"key":"BFnm1113_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner, G.G. & Wong, C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885\u2013890 (1984).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm1113_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1899488","volume":"251","author":"VM-Y Lee","year":"1991","unstructured":"Lee, V.M.-Y., Balin, B.J., Otvos, L., Jr. & Trojanowski, J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251, 675\u2013678 (1991).","journal-title":"Science"},{"key":"BFnm1113_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M.G. et al. \u03b1-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"BFnm1113_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner, S.B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136\u2013144 (1982).","journal-title":"Science"},{"key":"BFnm1113_CR7","unstructured":"World Health Organization. Active ageing: a policy framework. Second United Nations World Assembly on Aging, Madrid, Spain (World Health Organization, Geneva, 2002). www.who.int\/hpr\/ageing\/ActiveAgingPolicyFrame.pdf"},{"key":"BFnm1113_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","volume":"60","author":"LE Hebert","year":"2003","unstructured":"Hebert, L.E., Scherr, P.A., Bienias, J.L., Bennett, D.A. & Evans, D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60, 1119\u20131122 (2003).","journal-title":"Arch. Neurol."},{"key":"BFnm1113_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.eurpsy.2003.03.003","volume":"18","author":"J Wancata","year":"2003","unstructured":"Wancata, J., Musalek, M., Alexandrowicz, R. & Krautgartner, M. Number of dementia sufferers in Europe between the years 2000 and 2050. Eur. Psychiatry 18, 306\u2013313 (2003).","journal-title":"Eur. Psychiatry"},{"key":"BFnm1113_CR10","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1126\/science.1068408","volume":"295","author":"FU Hartl","year":"2002","unstructured":"Hartl, F.U. & Hayer-Hartl, M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295, 1852\u20131858 (2002).","journal-title":"Science"},{"key":"BFnm1113_CR11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/353844a0","volume":"353","author":"MC Chartier-Harlin","year":"1991","unstructured":"Chartier-Harlin, M.C. et al. Early-onset alzheimer's disease caused by mutations at codon 717 of the \u03b2-amyloid precursor protein gene. Nature 353, 844\u2013846 (1991).","journal-title":"Nature"},{"key":"BFnm1113_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev, E.I. et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775\u2013778 (1995).","journal-title":"Nature"},{"key":"BFnm1113_CR13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad, E. et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973\u2013977 (1995).","journal-title":"Science"},{"key":"BFnm1113_CR14","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754\u2013760 (1995).","journal-title":"Nature"},{"key":"BFnm1113_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704\u2013706 (1991).","journal-title":"Nature"},{"key":"BFnm1113_CR16","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1242\/jcs.113.11.1857","volume":"113","author":"B De Strooper","year":"2000","unstructured":"De Strooper, B. & Annaert, W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113, 1857\u20131870 (2000).","journal-title":"J. Cell Sci."},{"key":"BFnm1113_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.286.5441.916","volume":"286","author":"C Haass","year":"1999","unstructured":"Haass, C. & De Strooper, B. The presenilins in Alzheimer's disease\u2014proteolysis holds the key. Science 286, 916\u2013919 (1999).","journal-title":"Science"},{"key":"BFnm1113_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev.neuro.21.1.479","volume":"21","author":"DL Price","year":"1998","unstructured":"Price, D.L. & Sisodia, S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 21, 479\u2013505 (1998).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnm1113_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0896-6273(03)00205-8","volume":"38","author":"B De Strooper","year":"2003","unstructured":"De Strooper, B. Aph-1, Pen-2, and nicastrin with presenilin generate an active \u03b3-secretase complex. Neuron 38, 9\u201312 (2003).","journal-title":"Neuron"},{"key":"BFnm1113_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"BFnm1113_CR21","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E.H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"BFnm1113_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales, K.R. et al. Lack of apolipoprotein E dramatically reduces amyloid \u03b2-peptide deposition. Nat. Genet. 17, 263\u2013264 (1997).","journal-title":"Nat. Genet."},{"key":"BFnm1113_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1471-4914(03)00007-8","volume":"9","author":"J Poirier","year":"2003","unstructured":"Poirier, J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol. Med. 9, 94\u2013101 (2003).","journal-title":"Trends Mol. Med."},{"key":"BFnm1113_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli, L., Tanzi, R.E. & Kovacs, D.M. Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 6, 345\u2013351 (2003).","journal-title":"Nat. Neurosci."},{"key":"BFnm1113_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(01)00476-7","volume":"32","author":"RE Tanzi","year":"2001","unstructured":"Tanzi, R.E. & Bertram, L. New frontiers in Alzheimer's disease genetics. Neuron 32, 181\u2013184 (2001).","journal-title":"Neuron"},{"key":"BFnm1113_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen, S. et al. A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity. Nature 414, 212\u2013216 (2001).","journal-title":"Nature"},{"key":"BFnm1113_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2165\/00003495-200363080-00001","volume":"63","author":"L Launer","year":"2003","unstructured":"Launer, L. Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: dissecting the epidemiological evidence. Drugs 63, 731\u2013739 (2003).","journal-title":"Drugs"},{"key":"BFnm1113_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.mp.4001508","volume":"9","author":"J G\u00f6tz","year":"2004","unstructured":"G\u00f6tz, J. et al. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Mol. Psychiatry 9, 664\u2013683 (2004).","journal-title":"Mol. Psychiatry"},{"key":"BFnm1113_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1146\/annurev.neuro.26.041002.131425","volume":"26","author":"NM Bonini","year":"2003","unstructured":"Bonini, N.M. & Fortini, M.E. Human neurodegenerative disease modeling using Drosophila. Annu. Rev. Neurosci. 26, 627\u2013656 (2003).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnm1113_CR30","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J G\u00f6tz","year":"2001","unstructured":"G\u00f6tz, J., Chen, F., Van Dorpe, J. & Nitsch, R.M. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A\u03b242 fibrils. Science 293, 1491\u20131495 (2001).","journal-title":"Science"},{"key":"BFnm1113_CR31","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis, J. et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487\u20131491 (2001).","journal-title":"Science"},{"key":"BFnm1113_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo, S., Billings, L., Kesslak, J.P., Cribbs, D.H. & LaFerla, F.M. A\u03b2 immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321\u2013332 (2004).","journal-title":"Neuron"},{"key":"BFnm1113_CR33","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1088469","volume":"302","author":"A Monsonego","year":"2003","unstructured":"Monsonego, A. & Weiner, H.L. Immunotherapeutic approaches to Alzheimer's disease. Science 302, 834\u2013838 (2003).","journal-title":"Science"},{"key":"BFnm1113_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo, S., Billings, L., Kesslak, J.P., Cribbs, D.H. & LaFerla, F.M. A\u03b2 immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321\u2013332 (2004).","journal-title":"Neuron"},{"key":"BFnm1113_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM-Y Lee","year":"2001","unstructured":"Lee, V.M.-Y., Goedert, M. & Trojanowski, J.Q. Neurodegenerative tauopathies. Ann. Rev. Neurosci. 24, 1121\u20131159 (2001).","journal-title":"Ann. Rev. Neurosci."},{"key":"BFnm1113_CR36","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton, M. et al. Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702\u2013705 (1998).","journal-title":"Nature"},{"key":"BFnm1113_CR37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.410430617","volume":"43","author":"P Poorkaj","year":"1998","unstructured":"Poorkaj, P. et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815\u2013825 (1998).","journal-title":"Ann. Neurol."},{"key":"BFnm1113_CR38","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1073\/pnas.95.13.7737","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M.G. et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95, 7737\u20137741 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1113_CR39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1042\/bj3230577","volume":"323","author":"ML Billingsley","year":"1997","unstructured":"Billingsley, M.L. & Kincaid, R.L. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 323, 577\u2013591 (1997).","journal-title":"Biochem. J."},{"key":"BFnm1113_CR40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1750-3639.1999.tb00551.x","volume":"9","author":"SH Yen","year":"1999","unstructured":"Yen, S.H., Hutton, M., DeTure, M., Ko, L.W. & Nacharaju, P. Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17. Brain Pathol. 9, 695\u2013705 (1999).","journal-title":"Brain Pathol."},{"key":"BFnm1113_CR41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1062382","volume":"293","author":"CW Wittmann","year":"2001","unstructured":"Wittmann, C.W. et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711\u2013714 (2001).","journal-title":"Science"},{"key":"BFnm1113_CR42","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson, B.I. et al. Initiation and synergistic fibrillization of tau and \u03b1-synuclein. Science 300, 636\u2013640 (2003).","journal-title":"Science"},{"key":"BFnm1113_CR43","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert, M. \u03b1-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2, 492\u2013501 (2001).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnm1113_CR44","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M.H. et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"BFnm1113_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger, R. et al. Ala30Pro mutation in the gene encoding \u03b1-synuclein in Parkinson's disease. Nat. Genet. 18, 106\u2013108 (1998).","journal-title":"Nat. Genet."},{"key":"BFnm1113_CR46","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A.B. et al. \u03b1-Synuclein locus triplication causes Parkinson's disease. Science 302, 841 (2003).","journal-title":"Science"},{"key":"BFnm1113_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz, J.J. et al. The new mutation, E46K, of \u03b1-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164\u2013173 (2004).","journal-title":"Ann. Neurol."},{"key":"BFnm1113_CR48","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301\u20131306 (2000).","journal-title":"Nat. Neurosci."},{"key":"BFnm1113_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1749-6632.2003.tb07466.x","volume":"991","author":"H Ischiropoulos","year":"2003","unstructured":"Ischiropoulos, H. Oxidative modifications of \u03b1-synuclein. Ann. N.Y. Acad. Sci. 991, 93\u2013100 (2003).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BFnm1113_CR50","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrn1199","volume":"4","author":"E Maries","year":"2003","unstructured":"Maries, E., Dass, B., Collier, T.J., Kordower, J.H. & Steece-Collier, K. The role of \u03b1-synuclein in Parkinson's disease: insights from animal models. Nat. Rev. Neurosci. 4, 727\u2013738 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnm1113_CR51","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nm1102-1185","volume":"8","author":"PK Auluck","year":"2002","unstructured":"Auluck, P.K. & Bonini, N.M. Pharmacological prevention of Parkinson disease in Drosophila. Nat. Med. 8, 1185\u20131186 (2002).","journal-title":"Nat. Med."},{"key":"BFnm1113_CR52","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.1067389","volume":"295","author":"PK Auluck","year":"2002","unstructured":"Auluck, P.K., Chan, H.Y., Trojanowski, J.Q., Lee, V.M.-Y. & Bonini, N.M. Chaperone suppression of \u03b1-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865\u2013868 (2002).","journal-title":"Science"},{"key":"BFnm1113_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605\u2013608 (1998).","journal-title":"Nature"},{"key":"BFnm1113_CR54","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy, E. et al. The ubiquitin pathway in Parkinson's disease. Nature 395, 451\u2013452 (1998).","journal-title":"Nature"},{"key":"BFnm1113_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-8674(03)00509-9","volume":"114","author":"BI Giasson","year":"2003","unstructured":"Giasson, B.I. & Lee, V.M.-Y. Are ubiquitination pathways central to Parkinson's disease? Cell 114, 1\u20138 (2003).","journal-title":"Cell"},{"key":"BFnm1113_CR56","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati, V. et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256\u2013259 (2003).","journal-title":"Science"},{"key":"BFnm1113_CR57","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente, E.M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158\u20131160 (2004).","journal-title":"Science"},{"key":"BFnm1113_CR58","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi, H.Y. & Orr, H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217\u2013247 (2000).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnm1113_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77\u201379 (1991).","journal-title":"Nature"},{"key":"BFnm1113_CR60","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","volume":"90","author":"E Scherzinger","year":"1997","unstructured":"Scherzinger, E. et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549\u2013558 (1997).","journal-title":"Cell"},{"key":"BFnm1113_CR61","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0896-6273(00)81104-6","volume":"24","author":"X Lin","year":"1999","unstructured":"Lin, X., Cummings, C.J. & Zoghbi, H.Y. Expanding our understanding of polyglutamine diseases through mouse models. Neuron 24, 499\u2013502 (1999).","journal-title":"Neuron"},{"key":"BFnm1113_CR62","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/40153","volume":"389","author":"PJ Skinner","year":"1997","unstructured":"Skinner, P.J. et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971\u2013974 (1997).","journal-title":"Nature"},{"key":"BFnm1113_CR63","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0896-6273(00)80405-5","volume":"19","author":"CA Ross","year":"1997","unstructured":"Ross, C.A. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19, 1147\u20131150 (1997).","journal-title":"Neuron"},{"key":"BFnm1113_CR64","doi-asserted-by":"publisher","first-page":"16407","DOI":"10.1073\/pnas.152330499","volume":"99","author":"NM Bonini","year":"2002","unstructured":"Bonini, N.M. Chaperoning brain degeneration. Proc. Natl. Acad. Sci. USA 99, 16407\u201316411 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1113_CR65","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","volume":"35","author":"CA Ross","year":"2002","unstructured":"Ross, C.A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35, 819\u2013822 (2002).","journal-title":"Neuron"},{"key":"BFnm1113_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coph.2003.09.008","volume":"4","author":"MM Lipinski","year":"2004","unstructured":"Lipinski, M.M. & Yuan, J. Mechanisms of cell death in polyglutamine expansion diseases. Curr. Opin. Pharmacol. 4, 85\u201390 (2004).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnm1113_CR67","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","volume":"292","author":"NF Bence","year":"2001","unstructured":"Bence, N.F., Sampat, R.M. & Kopito, R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552\u20131555 (2001).","journal-title":"Science"},{"key":"BFnm1113_CR68","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0896-6273(03)00328-3","volume":"38","author":"AR La Spada","year":"2003","unstructured":"La Spada, A.R. & Taylor, J.P. Polyglutamines placed into context. Neuron 38, 681\u2013684 (2003).","journal-title":"Neuron"},{"key":"BFnm1113_CR69","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/01.WNL.0000055861.95202.8D","volume":"60","author":"C Lomen-Hoerth","year":"2003","unstructured":"Lomen-Hoerth, C. et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60, 1094\u20131097 (2003).","journal-title":"Neurology"},{"key":"BFnm1113_CR70","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","volume":"27","author":"LI Bruijn","year":"2004","unstructured":"Bruijn, L.I., Miller, T.M. & Cleveland, D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723\u2013749 (2004).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnm1113_CR71","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng1001-166","volume":"29","author":"S Hadano","year":"2001","unstructured":"Hadano, S. et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29, 166\u2013173 (2001).","journal-title":"Nat. Genet."},{"key":"BFnm1113_CR72","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ng1001-160","volume":"29","author":"Y Yang","year":"2001","unstructured":"Yang, Y. et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29, 160\u2013165 (2001).","journal-title":"Nat. Genet."},{"key":"BFnm1113_CR73","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ng1123","volume":"33","author":"I Puls","year":"2003","unstructured":"Puls, I. et al. Mutant dynactin in motor neuron disease. Nat. Genet. 33, 455\u2013456 (2003).","journal-title":"Nat. Genet."},{"key":"BFnm1113_CR74","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1126\/science.1083129","volume":"300","author":"M Hafezparast","year":"2003","unstructured":"Hafezparast, M. et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300, 808\u2013812 (2003).","journal-title":"Science"},{"key":"BFnm1113_CR75","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D.R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362 (1993).","journal-title":"Nature"},{"key":"BFnm1113_CR76","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0092-8674(01)00244-6","volume":"104","author":"JP Julien","year":"2001","unstructured":"Julien, J.P. Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded. Cell 104, 581\u2013591 (2001).","journal-title":"Cell"},{"key":"BFnm1113_CR77","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","volume":"281","author":"LI Bruijn","year":"1998","unstructured":"Bruijn, L.I. et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851\u20131854 (1998).","journal-title":"Science"},{"key":"BFnm1113_CR78","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1126\/science.1086071","volume":"302","author":"AM Clement","year":"2003","unstructured":"Clement, A.M. et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113\u2013117 (2003).","journal-title":"Science"},{"key":"BFnm1113_CR79","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0092-8674(00)81163-0","volume":"93","author":"SB Prusiner","year":"1998","unstructured":"Prusiner, S.B., Scott, M.R., DeArmond, S.J. & Cohen, F.E. Prion protein biology. Cell 93, 337\u2013348 (1998).","journal-title":"Cell"},{"key":"BFnm1113_CR80","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0140-6736(99)05128-4","volume":"354","author":"J Collinge","year":"1999","unstructured":"Collinge, J. Variant Creutzfeldt-Jakob disease. Lancet 354, 317\u2013323 (1999).","journal-title":"Lancet"},{"key":"BFnm1113_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(03)15171-9","volume":"363","author":"SJ Collins","year":"2004","unstructured":"Collins, S.J., Lawson, V.A. & Masters, C.L. Transmissible spongiform encephalopathies. Lancet 363, 51\u201361 (2004).","journal-title":"Lancet"},{"key":"BFnm1113_CR82","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/370471a0","volume":"370","author":"DA Kocisko","year":"1994","unstructured":"Kocisko, D.A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471\u2013474 (1994).","journal-title":"Nature"},{"key":"BFnm1113_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/bmb\/66.1.43","volume":"66","author":"C Weissmann","year":"2003","unstructured":"Weissmann, C. & Flechsig, E. PrP knock-out and PrP transgenic mice in prion research. Br. Med. Bull. 66, 43\u201360 (2003).","journal-title":"Br. Med. Bull."},{"key":"BFnm1113_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0092-8674(95)90236-8","volume":"83","author":"GC Telling","year":"1995","unstructured":"Telling, G.C. et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79\u201390 (1995).","journal-title":"Cell"},{"key":"BFnm1113_CR85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1126\/science.279.5347.42","volume":"279","author":"B Chesebro","year":"1998","unstructured":"Chesebro, B. BSE and prions: uncertainties about the agent. Science 279, 42\u201343 (1998).","journal-title":"Science"},{"key":"BFnm1113_CR86","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.1100195","volume":"305","author":"G Legname","year":"2004","unstructured":"Legname, G. et al. Synthetic mammalian prions. Science 305, 673\u2013676 (2004).","journal-title":"Science"},{"key":"BFnm1113_CR87","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1212\/WNL.58.12.1720","volume":"58","author":"P Brown","year":"2002","unstructured":"Brown, P. Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology 58, 1720\u20131725 (2002).","journal-title":"Neurology"},{"key":"BFnm1113_CR88","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1146\/annurev.micro.56.013002.100603","volume":"56","author":"SM Uptain","year":"2002","unstructured":"Uptain, S.M. & Lindquist, S. Prions as protein-based genetic elements. Annu. Rev. Microbiol. 56, 703\u2013741 (2002).","journal-title":"Annu. Rev. Microbiol."},{"key":"BFnm1113_CR89","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nature02391","volume":"428","author":"CY King","year":"2004","unstructured":"King, C.Y. & Diaz-Avalos, R. Protein-only transmission of three yeast prion strains. Nature 428, 319\u2013323 (2004).","journal-title":"Nature"},{"key":"BFnm1113_CR90","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature02392","volume":"428","author":"M Tanaka","year":"2004","unstructured":"Tanaka, M., Chien, P., Naber, N., Cooke, R. & Weissman, J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 428, 323\u2013328 (2004).","journal-title":"Nature"},{"key":"BFnm1113_CR91","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/jnen\/62.11.1087","volume":"62","author":"DS Knopman","year":"2003","unstructured":"Knopman, D.S. et al. Neuropathology of cognitively normal elderly. J. Neuropathol. Exp. Neurol. 62, 1087\u20131095 (2003).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnm1113_CR92","doi-asserted-by":"publisher","first-page":"14675","DOI":"10.1073\/pnas.261562998","volume":"98","author":"M Koistinaho","year":"2001","unstructured":"Koistinaho, M. et al. Specific spatial learning deficits become severe with age in \u03b2 -amyloid precursor protein transgenic mice that harbor diffuse \u03b2-amyloid deposits but do not form plaques. Proc. Natl. Acad. Sci. USA 98, 14675\u201314680 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1113_CR93","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey, B. & Lansbury, P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267\u2013298 (2003).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnm1113_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-8674(00)81743-2","volume":"95","author":"SS Sisodia","year":"1998","unstructured":"Sisodia, S.S. Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial? Cell 95, 1\u20134 (1998).","journal-title":"Cell"},{"key":"BFnm1113_CR95","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(00)81781-X","volume":"95","author":"IA Klement","year":"1998","unstructured":"Klement, I.A. et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41\u201353 (1998).","journal-title":"Cell"},{"key":"BFnm1113_CR96","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1073725","volume":"298","author":"J Ma","year":"2002","unstructured":"Ma, J., Wollmann, R. & Lindquist, S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 1781\u20131785 (2002).","journal-title":"Science"},{"key":"BFnm1113_CR97","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1083\/jcb.200108057","volume":"156","author":"K Stamer","year":"2002","unstructured":"Stamer, K., Vogel, R., Thies, E., Mandelkow, E. & Mandelkow, E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156, 1051\u20131063 (2002).","journal-title":"J. Cell Biol."},{"key":"BFnm1113_CR98","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D.M. et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535\u2013539 (2002).","journal-title":"Nature"},{"key":"BFnm1113_CR99","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway, K.A., Harper, J.D. & Lansbury, P.T. Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318\u20131320 (1998).","journal-title":"Nat. Med."},{"key":"BFnm1113_CR100","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1126\/science.1067122","volume":"296","author":"JP Taylor","year":"2002","unstructured":"Taylor, J.P., Hardy, J. & Fischbeck, K.H. Toxic proteins in neurodegenerative disease. Science 296, 1991\u20131995 (2002).","journal-title":"Science"},{"key":"BFnm1113_CR101","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nature02264","volume":"426","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe, D.J. Folding proteins in fatal ways. Nature 426, 900\u2013904 (2003).","journal-title":"Nature"},{"key":"BFnm1113_CR102","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archneur.57.6.793","volume":"57","author":"B Wolozin","year":"2000","unstructured":"Wolozin, B. & Behl, C. Mechanisms of neurodegenerative disorders: Part 1: protein aggregates. Arch. Neurol. 57, 793\u2013796 (2000).","journal-title":"Arch. Neurol."},{"key":"BFnm1113_CR103","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neuron.2004.06.016","volume":"43","author":"J Liu","year":"2004","unstructured":"Liu, J. et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43, 5\u201317 (2004).","journal-title":"Neuron"},{"key":"BFnm1113_CR104","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2004.06.021","volume":"43","author":"P Pasinelli","year":"2004","unstructured":"Pasinelli, P. et al. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43, 19\u201330 (2004).","journal-title":"Neuron"},{"key":"BFnm1113_CR105","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.expneurol.2004.01.031","volume":"187","author":"MS Forman","year":"2004","unstructured":"Forman, M.S. Genotype-phenotype correlations in FTDP-17: does form follow function? Exp. Neurol. 187, 229\u2013234 (2004).","journal-title":"Exp. Neurol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1113","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:11:11Z","timestamp":1684447871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,30]]},"references-count":105,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["BFnm1113"],"URL":"https:\/\/doi.org\/10.1038\/nm1113","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,30]]}}}